Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites

E Ebrahimi, A Sangphukieo, HA Park, V Gaborieau, A Ferreiro-Iglesias, B Diergaarde, W Ahrens, L Alemany, LMRB Arantes, J Betka, SV Bratman, C Canova, MSC Conlon, DI Conway, M Cuello, M Curado, A de Carvalho, J de Oliviera, M Gormley, M Hadji, S Hargreaves, CM Healy, I Holcatova, RJ Hung, LP Kowalski, P Lagiou, A Lagiou, G Liu, GJ Macfarlane, AF Olshan, S Perdomo, LF Pinto, JV Podesta, J Polesel, M Pring, H Rashidian, RR Gama, L Richiardi, M Robinson, PA Rodriguez-Urrego, SA Santi, DP Saunders, SC Soares-Lima, N Timpson, M Vilensky, SV von Zeidler, T Waterboer, K Zendehdel, A Znaor, P Brennan, HEADSpAcE Consortium, J McKay, S Virani, T Dudding
doi: https://doi.org/10.1101/2024.11.18.24317473

Article Information

doi 
https://doi.org/10.1101/2024.11.18.24317473
History 
  • November 18, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. E Ebrahimi1,2,
  2. A Sangphukieo1,3,
  3. HA Park1,
  4. V Gaborieau1,
  5. A Ferreiro-Iglesias1,
  6. B Diergaarde4,
  7. W Ahrens5,
  8. L Alemany6,7,8,
  9. LMRB Arantes9,
  10. J Betka10,
  11. SV Bratman11,
  12. C Canova12,
  13. MSC Conlon13,
  14. DI Conway14,
  15. M Cuello15,
  16. M Curado16,
  17. A de Carvalho1,
  18. J de Oliviera17,
  19. M Gormley18,
  20. M Hadji2,19,
  21. S Hargreaves20,
  22. CM Healy21,
  23. I Holcatova22,
  24. RJ Hung23,24,
  25. LP Kowalski25,26,
  26. P Lagiou27,
  27. A Lagiou28,
  28. G Liu29,
  29. GJ Macfarlane30,
  30. AF Olshan31,
  31. S Perdomo1,
  32. LF Pinto32,
  33. JV Podesta33,
  34. J Polesel34,
  35. M Pring18,
  36. H Rashidian2,
  37. RR Gama35,
  38. L Richiardi36,
  39. M Robinson37,
  40. PA Rodriguez-Urrego38,
  41. SA Santi39,
  42. DP Saunders40,
  43. SC Soares-Lima41,
  44. N Timpson42,
  45. M Vilensky43,
  46. SV von Zeidler44,
  47. T Waterboer45,
  48. K Zendehdel2,
  49. A Znaor46,
  50. P Brennan1,
  51. HEADSpAcE Consortium47,
  52. J McKay1,
  53. S Virani1,* and
  54. T Dudding18,*
  1. 1Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
  2. 2Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  4. 4Department of Human Genetics, School of Public Health, University of Pittsburgh, and UPMC Hillman Cancer Center, Pittsburgh, USA
  5. 5Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany
  6. 6Catalan Institute of Oncology. ICO, L’Hospitalet, Barcelona, Spain
  7. 7Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet, Barcelona, Spain
  8. 8CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
  9. 9Barretos Cancer Hospital, Barretos, Brazil
  10. 10Department of Otorhinolarygology and Head And Neck Surgery, 1.st Medical Faculty, Charles University, Faculty Hospital Motol, Prague, Czech Republic
  11. 11Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
  12. 12Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padova, Italy
  13. 13Epidemiology, Outcomes & Evaluation Research, Health Sciences North Research Institute, Sudbury, Canada
  14. 14School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK
  15. 15Oncology, Hospital de Clinicas Dr. Manuel Quintela, Montevideo, Uruguay
  16. 16Epidemiology and Statistics Group, Research Center, A.C Camargo Cancer Center, São Paulo, Brazil
  17. 17Araújo Jorge Cancer Hospital, Associação de Combate ao Câncer em Goiás, Goiania, Brazil
  18. 18Bristol Dental School, Bristol University, Bristol, UK
  19. 19A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
  20. 20University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
  21. 21School of Dental Science, Dublin Dental University Hospital, Trinity College Dublin, Dublin, Ireland
  22. 22Institute of Hygiene & Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
  23. 23Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada
  24. 24Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
  25. 25Department of Head and Neck Surgery, University of São Paulo Medical School, São Paulo, Brazil
  26. 26Department of Head and Neck Surgery and Otorhinolaryngology, A C Camargo Cancer Center, São Paulo, Brazil
  27. 27Department of Hygiene, Epidemiology & Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
  28. 28Department of Public and Community Health, School of Public Health, University of West Attica, Athens, Greece
  29. 29Medicine, Epidemiology, Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
  30. 30Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
  31. 31Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA
  32. 32Programa de Carcinogênese Molecular, Instituto Nacional de Câncer - INCA, Rio de Janeiro, Brazil
  33. 33Head and Neck Surgery Division, Women’s Association for Education and Fight Against Cancer/AFECC, Vitória, Brazil
  34. 34Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
  35. 35Department of Head and Neck Surgery, Barretos Cancer Hospital, São Paulo, Brazil
  36. 36Cancer Epidemiology Unit, University of Turin, Turin, Italy
  37. 37Cellular Pathology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  38. 38Pathology and Laboratories, Pathology, University Hospital Fundacion Santa Fe de Bogota, Bogota, Colombia
  39. 39Clinical Oncology Research, Health Sciences North Research Institute, Sudbury, Canada
  40. 40Department of Dental Oncology, Health Sciences North, Northern Ontario School of Medicine University, Sudbury, Canada
  41. 41Brazilian National Cancer Institute, Rio de Janeiro, Brazil
  42. 42MRC Integrative Epidemiology Unit, Bristol University, Bristol, UK
  43. 43Instituto de Oncologia Angel H Roffo, Universidad de Buenos Aires, Buenos Aires, Argentina
  44. 44Pathology Department, Federal University of Espírito Santo, Vitória, Brazil
  45. 45Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
  46. 46Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
  1. ↵*Co-last, co-corresponding authors: Shama Virani viranis{at}iarc.who.int, *Tom Dudding tom.dudding{at}bristol.ac.uk
Back to top
Posted November 18, 2024.
Download PDF

Supplementary Material

Email
Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites
E Ebrahimi, A Sangphukieo, HA Park, V Gaborieau, A Ferreiro-Iglesias, B Diergaarde, W Ahrens, L Alemany, LMRB Arantes, J Betka, SV Bratman, C Canova, MSC Conlon, DI Conway, M Cuello, M Curado, A de Carvalho, J de Oliviera, M Gormley, M Hadji, S Hargreaves, CM Healy, I Holcatova, RJ Hung, LP Kowalski, P Lagiou, A Lagiou, G Liu, GJ Macfarlane, AF Olshan, S Perdomo, LF Pinto, JV Podesta, J Polesel, M Pring, H Rashidian, RR Gama, L Richiardi, M Robinson, PA Rodriguez-Urrego, SA Santi, DP Saunders, SC Soares-Lima, N Timpson, M Vilensky, SV von Zeidler, T Waterboer, K Zendehdel, A Znaor, P Brennan, HEADSpAcE Consortium, J McKay, S Virani, T Dudding
medRxiv 2024.11.18.24317473; doi: https://doi.org/10.1101/2024.11.18.24317473
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area